TGM2 and nonpapillary renal cell carcinoma: This analysis, performed on transcriptomic data of 468 patients, showed that altered expressions of AKR1C1, AKR1C2, SLC7A5, NMI, PLAU, TBC1D2, TGM2, and WIZ correlated with poor survival of ccRCC patients.